Clinical Trial Update: Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated the safety and effectiveness of a hydrogel used after removal of uterine fibroids during gynecologic surgery to reduce postoperative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Hydrogel (hydrogel)

Snippet

Sponsor: Angiotech Pharmaceuticals | Conditions: Myoma | Phase 1, Phase 2 | Status: COMPLETED